Login / Signup

Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study).

Dominik StrzeleckiMałgorzata Urban-KowalczykAdam Wysokiński
Published in: Human psychopharmacology (2018)
Sarcosine does not significantly affect IL-6 concentrations but IL-6 may be involved in mechanisms related to the presence of positive symptoms.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • patient reported outcomes
  • physical activity
  • depressive symptoms
  • sleep quality